XML 52 R59.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Intangible Assets - Schedule Of Finite-Lived Intangible Assets (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended 6 Months Ended 6 Months Ended 6 Months Ended
Jul. 27, 2014
Jan. 26, 2014
Jul. 27, 2014
Developed Technology [Member]
Jan. 26, 2014
Developed Technology [Member]
Jul. 27, 2014
Developed Technology [Member]
Minimum [Member]
Jul. 27, 2014
Developed Technology [Member]
Maximum [Member]
Jul. 27, 2014
Customer Relationships [Member]
Jan. 26, 2014
Customer Relationships [Member]
Jul. 27, 2014
Customer Relationships [Member]
Minimum [Member]
Jul. 27, 2014
Customer Relationships [Member]
Maximum [Member]
Jul. 27, 2014
Technology Licenses [Member]
Jan. 26, 2014
Technology Licenses [Member]
Jul. 27, 2014
Technology Licenses [Member]
Minimum [Member]
Jul. 27, 2014
Technology Licenses [Member]
Maximum [Member]
Jul. 27, 2014
Other Intangible Assets [Member]
Jan. 26, 2014
Other Intangible Assets [Member]
Jul. 27, 2014
Other Intangible Assets [Member]
Minimum [Member]
Jul. 27, 2014
Other Intangible Assets [Member]
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]                                    
Estimated useful life         2 years 10 years     7 years 10 years     5 years 10 years     1 year 5 years
Gross carrying amount $ 186,997 $ 185,997 $ 146,925 $ 146,925     $ 28,630 $ 28,630     $ 4,842 [1] $ 3,842 [1]     $ 6,600 $ 6,600    
Accumulated amortization (62,696) (49,053) (45,817) (35,357)     (9,579) (7,505)     (1,103) [1] (367) [1]     (6,197) (5,824)    
Net carrying amount $ 124,301 $ 136,944 $ 101,108 $ 111,568     $ 19,051 $ 21,125     $ 3,739 [1] $ 3,475 [1]     $ 403 $ 776    
[1] Technology licenses relate to in-license agreements for intellectual property that is used by the Company in research and development activities and also has alternative future uses. Amortization expense related to technology licenses is reported as “Product development and engineering” in the condensed consolidated statements of income.